Supplemental Figure 1 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
Autor: | Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois |
---|---|
Rok vydání: | 2023 |
Popis: | Supplemental Figure 1 |
Databáze: | OpenAIRE |
Externí odkaz: |